Studies demonstrated that synthetic high-density lipoprotein nanodiscs can be used as clinically safe and scalable nanomaterials to facilitate the delivery of peptide neo-antigens through disulfide conjugation, and cholesterol-modified adjuvant therapy to draining lymph nodes can be effective in treating cancer by inducing antigen-specific CD8+ T cell responses [78]. The gene discussed is CD8A; the disease is cancer.